Category: Pharmaceutical

Categories
Pharmaceutical

Immunodermatology Market Expecting the Unexpected future in 2031; SWOT analysis, investment feasibility analysis

According to a report by Fact.MR, the immunodermatology market is expected to post significant gains through 2021 and beyond. Expansion of the market is underpinned by growing prevalence of skin disorders such as atopic dermatitis, psoriasis, and other conditions. The market is anticipated to witness an unprecedented upsurge through 2031, with surging cases of incurable and rare skin disorders, especially among children.

According to the report of Genetic and Rare Diseases, around 900 million people are suffering from skin disorders since 2018. Among which, approximately 9.6 million children were affected with atopic dermatitis in 2020 and over 31.6 million people in the U.S. have some form of eczema. Acknowledging this burden, healthcare professionals are increasing research & development activities in manufacturing novel drugs, stimulating the demand for immunodermatology. Hence, rising demand for drug therapies and product approvals are some of the factors augmenting market growth.   

Request a report sample to gain comprehensive insights at

https://www.factmr.com/connectus/sample?flag=S&rep_id=5649

According to the study, increasing investment in development of novel pipeline drugs is expected to provide lucrative growth opportunities for the key players over the coming years. Also, growing demand for effective skin treatment and fast-track drug approval for novel immunodermatological drugs across emerging economies such as India, China and Japan is aiding the demand.

“Growing willingness to adopt high-quality and cost-effective treatments and increasing awareness regarding skin disorders are creating opportunities for early diagnosis of various skin conditions. This is expected to create attractive opportunities for growth,” says the Fact.MR analyst.

Key Takeaways from Fact.MR’s Immunodermatology Study

  • By type, atopic dermatitis is expected to account for major chuck of share in the global immunodermatology market, psoriasis catching up
  • By diagnosis, immunofluorescence testing is likely to remain primary choice for medical practitioners
  • Demand for drug therapy and gene therapy are expected to experience major incline
  • High demand for immunodermatological drugs likely in the US market, owing to rising cases of atopic dermatitis
  • Fast-track drug renewals and approvals are anticipated to widen sales prospects across the UK
  • Germany is expected to emerge as Europe’s leading immunodermatology market through 2021 and beyond
  • India and China are expected to lead the Asia Pacific immunodermatology market backed by the rising cases of dermatitis among children

Prominent Drivers

  • Rising incidence of allergies and skin diseases is expected to bolster the demand of immunodermatology
  • Surging demand for effective therapies and dermatological drugs for treating skin disorders will boost the market growth
  • Increasing healthcare expenditure and growing research activities for novel drug development for skin disorders will drive the demand

Discover more about the immunodermatology market with figures and data tables, along with the table of contents. https://www.factmr.com/connectus/sample?flag=T&rep_id=5649

Key Restraints

  • Documented side-effects and allergies arising out of skin diseases medicine consumption are likely to hinder future sales prospects
  • Stringent regulatory provisions regarding drug approvals is limiting adequate availability in the market

Competitive Landscape

Prominent Immunodermatology market players profiled by Fact.MR include Novartis AG, Abbvie, Valeant Pharmaceuticals, Bausch Health, Glenmark Pharmaceuticals Inc., Astellas Pharma, Novopharm Limited, Aspen Pharmacare Inc., Prometheus Laboratories, Taro Pharmaceuticals Inc., and Nucare Pharmaceuticals Inc. Key players are adopting various strategies such as mergers & acquisition, and are launching new products to strengthen their position in the industry.

For instance, in April 2020, KSL Biomedical Inc., a leading developer of novel companion diagnostic & therapeutic applications for immunology and oncology, announced the acquisition of Beutner Laboratories, an innovator in immunodermatology.

Also, Arcutis Biotherapeutics, Inc., a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, in December 2020 announced continued progress and future growth drivers related to its immuno-dermatology platform and pipeline on Virtual Investor Day to expand the company’s product portfolio.

More Insights on the Immunodermatology Market

Fact.MR, in its new offering, brings to fore an unbiased analysis of the global immunodermatology market. The study divulges compelling insights on the market based on type (systemic sclerosis, dermatomyositis, psoriasis, vitiligo, alopecia areata, lichen sclerosus, allergic dermatitis, atopic dermatitis, lupus erythematosus, blistering diseases, and connective tissue diseases), diagnosis (immunofluorescence testing, biopsy and blood test), therapy (drug therapy, intensed pulsed light therapy, stem cell therapy, and gene therapy), mode of administration (oral, topical, and intravenous) across key regions (North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa).

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/increasing-and-consistent-investments-for-healthcare-infrastructural-development-is-key-for-driving-neuralgia-treatment-market/

Explore Fact.MR’s Coverage on the Healthcare Domain

Dermatology Devices Market: A recent report by Fact.MR provides an in-depth analysis about the global dermatology devices market for the forthcoming decade.

Dermatology Diagnostic Devices Market: The scope of this Fact.MR’s report is to analyze the global dermatology diagnostic devices market for the upcoming forecast period, and provide readers an unbiased and accurate analysis.

Necrotizing Skin Infections Treatment Market: A recent study by Fact.MR on the necrotizing skin infections treatment market offers a forecast from 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market.

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Originator Small Molecule Drug Market is anticipated to show a robust growth rate during the forecasted period of 2021-2031

Evolving need for drug targets to treat cancer, epilepsy, diabetes and various other dreaded diseases is set to provide lucrative opportunity for small molecule drug demand. The use of diverse originator small molecule drugs varying from different humane ailments such as cold, cough and fever to attract huge customer engagement and make market get propelled.

The Market Research Survey by “Fact.MR, A Market Research and Competitive Intelligence Provider” highlights the key reasons behind increasing Demand of Originator Small Molecule Drug. The new Originator Small Molecule Drug market analysis report outlines the key factors that will impact sales, production and supply during the assessment 2021-2031. The report highlights the Originator Small Molecule Drug market key trends that are expected to influence the overall dynamics, and Originator Small Molecule Drug market size and share.

To Get In-depth Insights Request for Brochure here – https://www.factmr.com/connectus/sample?flag=B&rep_id=1519

Key Segments

By Drug Class

  • Anticholinergic
  • Anti-cancer
  • Others

By Indication Type

  • Cardiovascular
  • Oncology
  • Diabetes
  • Immunological disorders
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Clinics

Key questions answered in Originator Small Molecule Drug Market Survey Report:

  • What is the current scenario and key trends in Originator Small Molecule Drug Market?
  • What are the key strategies companies are adopting to increase their consumer base?
  • What are the key categories within the Originator Small Molecule Drug segments and their future potential?
  • What are the major Originator Small Molecule Drug Market drivers and their expected impact during the short, medium, and long terms?
  • What is the Originator Small Molecule Drug Market size and what are the opportunities for the key players?

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=1519

Who are the Key Manufacturers and Suppliers of Originator Small Molecule Drug?

Some of the leading manufacturers and suppliers of originator small molecule drugs include

  • Roche
  • Genentech
  • Amgen Inc.
  • Boehringer Ingelheim International GmbH
  • Novartis AG
  • Gilead
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline Plc.
  • Others

The majority of the industry giants in the originator small molecule drug industry have held a creative product range and offer highly effective drugs. Manufacturers choose to play with organic market strategy by innovating new production technologies &some other hybrid strategies to reach a clientele and gain a competitive edge over competitors. Manufacturers are also observed to expand their capacity and geographical presence to reinforce their position.

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, Rest Of MEA)

North America to remain the Supreme Region

The United States is one of the world’s biggest markets for small molecule drug. During the time frame 2021-2031, the US small molecule drug market is expected to emulate huge push. As the demand for drugs to treat various diseases is on highly increasing note, market is expected to show huge growth in the coming years.

Canada to also project huge spending on development of originator small molecule drug owing to the inclination of governing bodies towards huge expenditure allocation to healthcare system and to facilitate various drugs to treat different diseases. North America as a region with highly favorable reimbursements to remain as the most dominating globally.

Read More Trending and Similar Reports from Fact.MR – http://www.globenewswire.com/en/news-release/2018/01/16/1289681/0/en/6-Key-Takeaways-from-Fact-MR-s-Report-on-MDM-BPO-Market-for-Forecast-Period-2017-2026.html

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Tumor Embolization Market: North America is expected to be the leading region says Fact.MR Report

The global tumor embolization market study, currently being undertaken by consulting firm Fact.MR, forecasts a relatively positive growth outlook for FY 2021-22, compared to the previous year. Resumption of embolization procedures on a larger scale in the aftermath of the coronavirus pandemic are largely expected to restore the said projections

According to Fact.MR’s study, tumor embolization sales are heavily reliant on surging treatment volumes for liver cancers. The American Cancer Society’s estimates for primary liver cancer and intrahepatic bile duct cancer in the US for 2021 include over 42,000 new diagnoses and over 30,000 fatalities. This signifies an over threefold increase in incidence rates and doubling of death rates since 1980.

Consequently, healthcare expenditure to address the same is increasing manifold. A recent study discovered that overall direct costs for patients with hepatocellular carcinoma (HCC) ranged from US$ 29,355 to US$ 58,529, with median costs pegged at US$ 176,456 per patient annually. Majority of these expenses are directed towards availing tumor embolization treatments, expanding growth prospects.

For more insights into the Market, Request a Sample of this Report https://www.factmr.com/connectus/sample?flag=S&rep_id=3997

Key Takeaways from Fact.MR’s Tumor Embolization Market Study

  • Tumor embolization microcoils are expected to grab major eyeballs amid heightened safety concerns
  • By indication, tumor embolization for paraganglioma is likely to capture the maximum revenue share
  • Cancer treatment centers are poised to emerge as one of the most extensive tumor embolization end-users
  • US to record impressive sales amid growing diagnosis and treatment procedures for skin cancers
  • Rising Yttrium-90 redioembolization procedures to treat liver cancers driving sales across UK
  • Rising cancer research and treatment initiatives catapulting tumor embolization sales across Germany and France
  • India and China to garner lucrative market shares, driven by rising surgical procedures to treat breast and colorectal cancers

Tumor Embolization Market- Prominent Drivers

  • Increasing prevalence of oncogenic and non-oncogenic tumors accelerating tumor embolization sales across the world
  • Nanotechnology based embolization procedures, including microspheres or microbeads, are widening growth prospects
  • Ever-widening scope of interventional oncology is opening doors for tumor embolization market revenue expansion

Tumor Embolization Market- Key Restraints

  • Mixing of microbeads with radioactive isotopes to destroy malignant cells may also damage healthy tissue, limiting uptake
  • High risks of surgical laceration infections made during the embolization process is likely to restrain growth

Discover more about the tumor embolization market with figures, data tables and the table of contents. You will also find detailed market segmentation on https://www.factmr.com/report/3997/tumor-embolization-market

Competitive Landscape

Microvention Inc., Kaneka Pharma Europe NV, Penumbra Inc., DePuy Synthes, Cook Medical, Deutschland GmBh & Co. KG, Boston Scientific Corporation, Balt Extrusion, AngioDynamics and Varian Medical Systems Inc. are some highly prominent tumor embolization manufacturers profiled by Fact.MR’s ongoing study. A combination of organic expansion strategies such as product launches and approvals, as well as inorganic approaches such as acquisitions, partnerships and collaborations are also relied upon.

  • In January 2021, Microvention Inc. announced the FDA approval of the PMA Supplement for the WEB 17 System, a new addition to the WEB Aneurysm Embolization System for treating intracranial wide neck bifurcation aneurysms. This system is designed with the latest microbraid technology, featuring a lower profile delivery system compatible with the VIATM 17 micro catheter and includes additional device configurations.

Also, Penumbra Inc. manufactures the Penumbra SMART COIL® System, equipped with Ultra HD Fiber which is designed to be 3x stronger and 3x more flexible than polypropylene. It also features a single click instant mechanical detachment system for ease of use and reliability. It is used for a wide range of neurovascular lesions, including small, medium, and large-sized aneurysms.

More Insights on the Tumor Embolization Market

In its ongoing study, Fact.MR offers unbiased analysis of the global tumor embolization market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (NBCA glue, microspheres or microbeads and microcoils), indication (hemangioblastoma, juvenile nasal angiofibroma, meningioma, aneurysmal bone cyst, paraganglioma, hemangiopericytoma & others) and end users (hospitals, intensive care units, surgical centers and cancer treatment centers) across seven major regions (North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa).

Read More Trending and Similar Reports from Fact.MR – https://www.biospace.com/article/latest-insights-on-nano-healthcare-technology-market-post-covid-fact-mr-new-report-analyzes/

Explore Fact.MR’s Coverage on the Healthcare Domain

Kidney Cancer Diagnostics Market: The report on the global kidney cancer diagnostics market discusses such key factors that govern the economics of kidney cancer diagnostics across the globe.

Colorectal Cancer Diagnostics Market: The report on the global colorectal cancer diagnostics market discusses such key factors that govern the economics of colorectal cancer diagnostics across the globe.

OTC Herbal and Traditional Medicines Market: Traditional and herbal medicines have played an indispensable role in fulfilling the requirements of global healthcare. The consumer healthcare has been undergoing transformations, with principles of herbal and traditional medicines being rediscovered and introduced in the market. Growing consumer concerns related to health effects of synthetic drugs is expected fuel adoption of herbal and traditional medicines.

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Endoscope Tip Protectors Market foreseen to grow exponentially over 2019 to 2029

In a recent business intelligence study, Fact.MR presents the nitty-gritty of the global endoscope tip protectors market considering 2019–2029 as the stipulated timeframe. The business report highlights the drivers, restraints, opportunities and trends affecting market growth. Further, all the market shares associated with the market as well as the segments are expressed in terms of value and volume.

The endoscope tip protectors market study outlines the key regions – North America, Latin America, APEJ and Japan – along with the countries contributing the most in the respective regions. The report presents detailed insights about each market player, including SWOT analysis, main market information, market share, revenue, pricing and gross margin. Prominent players covered in this research are Medtrica Solutions Ltd., Meditech Endoscopy, Aspen Surgical, Medline Industries, Inc., and Olympus etc.

To Remain ‘Ahead’ Of Your Competitors, Request For A Sample – https://www.factmr.com/connectus/sample?flag=B&rep_id=3984

The endoscope tip protector’s market report addresses the below-mentioned queries:

  • Why are vendors shifting away from traditional methods of manufacturing endoscope tip protectors market?
  • How does the global endoscope tip protectors market looks like in the next five years?
  • Which end use industry is expected to surpass segment by the end of 2029?
  • What innovative products are being introduced by the players in the global endoscope tip protectors market?
  • Which regions are showing the fastest market growth?

On the basis of product type, the endoscope tip protectors market study consists of

  • Semi Rigid Mesh Protectors
  • Eye Piece Protectors

On the basis of end user, the endoscope tip protectors market study incorporates:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Crucial insights in the endoscope tip protectors market research:

  • Underlying macro- and microeconomic factors impacting the growth of the endoscope tip protectors market.
  • Basic overview of the endoscope tip protectors market, including market definition, classification, and applications.
  • Scrutinization of each endoscope tip protectors market player based on mergers & acquisitions, R&D projects, and product launches.
  • Adoption trend of endoscope tip protectors market across various industries.
  • Important regions and countries offering lucrative opportunities to endoscope tip protectors market stakeholders.

Get Customization on this Report for Specific Country: https://www.factmr.com/connectus/sample?flag=B&rep_id=3984

Endoscope Tip Protectors Market: Key Players

There are many key players manufacturing endoscope tip protectors. The companies manufacturing various endoscopic tip protectors are focusing on developing new and advanced products. Also, mergers, acquisitions and partnerships are the major strategies adopted by the key players. Examples of some of the key players operating in the global endoscope tip protectors market are

  • Medtrica Solutions Ltd.
  • Meditech Endoscopy
  • Aspen Surgical
  • Medline Industries, Inc.
  • Olympus etc.

Endoscope Tip Protectors Market: Regional Outlook

Geographically, the global endoscope tip protectors market is segmented into few key regions i.e. North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East and Africa. North America is expected to be the dominant market in the global endoscope tip protectors market due to technological advancements and presence of well-established healthcare infrastructure.

Europe is expected to register a large revenue share in the global endoscope tip protectors market throughout the forecast period. Countries like India, China are expected to show a significant growth in the endoscope tip protectors market due to increasing number of hospitals and increasing number of surgeries.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/long-term-disability-management-to-drive-bulk-of-medical-case-management-services-market-growth/

Explore Fact.MR’s Coverage on the Healthcare Domain

Bone Growth Stimulator Market: A recent study by Fact.MR on the bone growth stimulator market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth.

Bone Marrow Processing System Market: Fact.MR gives a detailed assessment of bone marrow processing system market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

Injectable Bone Graft Substitutes Market: Fact.MR delivers an in-depth analysis on global injectable bone graft substitutes market with the strategies and competitive landscape through 2021 and beyond. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Freezing Bags Market to Witness a Tremendous Growth Due to COVID-19 Pandemic – Exclusive Report by Fact.MR

The global freezing bags market is exhibiting steady growth and the trend is expected to continue for the forecast period between 2021 and 2031.

Rising demand for packaged food and growing disposable income of consumers are some of the key factors, fueling the freezing bag market growth across the globe. Besides this, increasing use of freezing bags for fruit, vegetables, and meat industries has created opportunities for growth of the global market for freezing bags, as per a study by Fact.MR.

Despite the growth, the COVID-19 outbreak had a major impact on the world economy. The pandemic had caused severe economic destruction due to the closure of manufacturing units and choked supply chain and logistics. Nonetheless, pharmaceutical and food industries are expected to emerge stronger as governments slowly ease restrictions imposed. With demand forecast to rise in the future, sales of freezing bags will continue rising at a positive rate.

Request a report sample to gain comprehensive insights at

https://www.factmr.com/connectus/sample?flag=S&rep_id=5189

Key Takeaways

  • The U.S exhibits high growth in the global freezing bags on the back of sophisticated lifestyles of the people and the growing food industry.
  • Growing urban population and increasing consumption of packaged food are the factors driving the growth of the freezing bags market in the U.K.
  • In terms of region, Asia Pacific is expected to dominate the freezing bags market due to its large consumer base and increasing inclination towards processed and frozen foods.
  • The Middle East and Africa are expected to be the least market growth segment owing to the less adaptability of the freezing bags.

 

Key Drivers

  • Changing lifestyles and the growing spending power of consumers across the globe are the factors fueling the demand for freezing bags.
  • Increasing number of retail stores across the globe is propelling the market growth in a positive way.
  • Rising purchasing power of the middle-class population in developing countries will push the sales of freezing bags in the market.

Key Restraints

  • Rising awareness among people to stop the use of plastic may hinder the market growth of freezing bags.
  • Growing regulations to prohibit the use of plastic may pose a challenge for growth for the global market of freezing bags.
  • Strict regulations and policy measures implemented by the government are restraining the growth freezing bag market.

Explore tables and figures of the study. Request ToC of the report at

https://www.factmr.com/connectus/sample?flag=T&rep_id=5189

Competitive Landscape

Prominent players in the freezing bag market include S. C. Johnson, Great American Packaging, The Glad Products Company, Reynolds Consumer Products, Elevate Packaging, Weston, NatureWorks, Rutan Poly Industries, Inc., Star Poly Bag, Inc., Abbey Polythene, Maxpak Australasia, Falcon Pack, Novamont, Convex Innovative Packaging among others. Some of them are investing in product developments and acquiring other companies to strengthen their presence. For instance,

  • In January 2021, Novamont acquired the complete BioBag Group which helped Novamont to expand its boundaries to North America, Australia, and North-Eastern Europe.
  • In September 2020, NatureWorks announced manufacturing technology projects which assisted NatureWorks to increase the availability of Ingeo (PLA) biomaterial portfolio.

More Insights on the Freezing Bag market:
In its latest report, Fact.MR offers an unbiased analysis of the freezing bag market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (reusable and disposable), material type (High-Density Polyethylene (HDPE), Medium Density Polyethylene (MDPE), and Low-Density Polyethylene (LDPE)), distribution channel (pharmaceutical industry, chemical industry, and food industry), distribution channel (offline stores and online stores), and across seven regions (North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa).

Read More Trending Reports of Fact.MR : https://www.biospace.com/article/growing-requirement-of-research-activities-to-fuel-demand-for-chromatography-syringes-market-states-fact-mr/

Explore Fact.MR’s Coverage on the Healthcare Domain
Shelf Stable Packaging Market: Fact.MR gives a detailed assessment of shelf stable packaging market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Conductive Plastic Compounds Market: Fact.MR’s expansive conductive plastic compounds market report sheds light on the prominent dynamics expected to shape future growth. The study explicates on the prominent drivers, opportunities and trends prevailing across key segments in prominent end users. Also, information regarding prominent key players has been embedded in the report.

Plastic Protective Packaging Market: Fact. MR’s extensive coverage on plastic protective packaging market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
 

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
 

Categories
Pharmaceutical

Asthma Spacers Market is poised to surpass US$ 1803.9 Mn by 2031-end

The global asthma spacers market is expected to grow moderately, at a CAGR of 3.9% between 2020 and 2026. The proliferation of respiratory illnesses such as asthma and allergies on back of pollution and smoking is paving the way for high demand growth of asthma spacers.  The geriatric population of the world is increasing rapidly and is exhibiting heightened disposition for respiratory disorders. Projections indicate that by 2050, more than one-fifth of the world’s population shall constitute the elderly.

Consequently, the number of asthma patients shall increase manifold. The World Health Organization predicts that by the end of 2025, an additional 100 million people shall contract asthma. At present, around 235 million people are affected by asthma. On the back of the aforementioned factors, the market shall surpass a value of US$ 1.8 Bn by the end of the forecast period. Moreover, difficulties using metered dose inhalers (MDI) is expected to further leverage the asthma spacers market.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4596

Key Takeaways of Asthma Spacers Market Study
  • Aerochambers shall gain significant traction during the forecast period. The segment shall account for more than two-fifth of the market share of the asthma spacers market. Delivery of medicine in a regulated manner and minimum wastage are key factors driving market growth.
  • Micro-spacers and flexi chambers are anticipated to exhibit moderate growth, accounting for a CAGR of 3.9% during the forecast period.
  • North America is set to remain the most attractive market for asthma spacers. A market share of 41% is predicted for the region during the forecast period, surpassing a valuation of US$ 739.61 Mn.
  • Asia-Pacific is catching up, expanding moderately at a CAGR of 4.5%. Burgeoning population, combined with increased expenditure on healthcare are key drivers behind the expansion of the asthma spacers market in the region.

global asthma spacers market 02 by FactMR

“The global asthma spacers market shows significant potential in the future. Growing incidence of asthma among the elderly, combined with a burgeoning population are contributing immensely to the expansion of the asthma spacers market,” concludes a Fact.MR analyst.

Request More Information about Report Methodology https://www.factmr.com/connectus/sample?flag=RM&rep_id=4596

Product Launches and Spontaneous Innovation to Determine Competition Landscape

The global asthma spacers market is highly fragmented. A number of small and large-scale companies operate in the market. The dominant players’ invest heavily in acquiring research and development businesses of smaller companies. Moreover, they also focused on launching new products. For instance, Trudell International invests in continuous innovation in order to broad base its market footprint. Its AEROCHAMBER PLUS FLOW-VU ensures that medicine is delivered where it is required. It consists of a dedicated inhalation indicator which helps co-ordinate actuation with inhalation. Another market player, Medical Developments International, focuses on spontaneous technological innovation to develop patient-friendly markers. For example, the company’s Anti-Static Compact Space Chamber Plus, is equipped with a Cross Valve Technology. This ensures proper delivery of medicine to asthma patients by providing low-resistance, one-way inhalation flow.

Get More Insights- https://www.biospace.com/article/asthma-spacers-demand-impacted-by-increased-incidences-of-asthma-says-fact-mr/

Looking for more information?

The research study on the asthma spacers market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global asthma spacers market over 2020-2026. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2026. Market statistics have been presented on the basis of product type (Aerochambers, Optichambers, Volumatic, Inspirease and Others) and distribution channel (Retail Pharmacy, e-Commerce and Hospital Pharmacy) across five major regions.

Explore Fact.MR’s Coverage on the Healthcare Domain

Radiation proctitis treatment market: A recent study by Fact.MR on the radiation proctitis treatment market offers a 10-year forecast analysis for the period 2018 to 2028. The study analyzes key trends that are currently determining the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Radiation Nephropathy Treatment and Management Market: Fact. MR’s extensive coverage on the radiation nephropathy treatment and management market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Cancer therapeutics market: The global cancer therapeutics market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/4596/asthma-spacers-market
Press Release: https://www.factmr.com/media-release/1368/global-asthma-spacers-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Histopathology Testing Equipment Market to register a CAGR of 4.8% by the end of 2026

Global sales of histopathology testing equipment surpassed US$ 5,300 Mn in 2017, with consumables leading the growth, according to the findings of a recently published study by Fact.MR.

Rising incidences of cancer and associated mortalities are driving the need for efficient tissue diagnosis. Moreover, growing inclination toward less-invasive diagnostic procedures for cancer and other malignancies drove growth of histopathology testing equipment.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=2240

“The American Cancer Society and National Center for Health Statistics have revealed that cancer cases in Unite States crossed 1,685,000 in 2017 and are likely to increase in the coming years. Likewise, according to WHO (World Health Organization) report, emerging economies such as India are witnessing an increase in cancer mortality rates with India reflecting 79 per 100,000 deaths. This has pushed the demand for efficient diagnosis of the disease, which is expected to translate into an increase in histopathology testing equipment sales crossing US$ 5,500 Mn by end of 2018”. –Lead Analyst, Fact.MR Medical Diagnostics Division

histopathology testing equipment market 1

Consumables are likely to account for nearly 80% revenue share of the market, according to the report. Demand for instruments in the histopathology testing equipment market is projected to expand at a relatively slow pace compared to consumables, making them a lucrative area for manufacturers from an investment standpoint.

Reagents and Antibodies to Spearhead Growth of Histopathology Testing Equipment Market

Sales of consumables in the histopathology testing equipment market are estimated to be on an upswing in 2018, says the report. The growth in sales of consumables is largely attributed to the increasing demand for reagents and antibodies. Increasing use of reagents and kits in genomics, sequencing and diagnosis of chronic diseases remains instrumental in driving their sales worldwide. Fact.MR envisages that demand for reagents and antibodies is projected to expand at a significant rate of over 5.5 % in the coming years.

The growth of histopathology testing equipment market is also influenced by macroeconomic aspects such as rising geriatric population. Increasing geriatric population is closely associated with chronic disorders and diseases, which is expected to push the demand for histopathology testing equipment worldwide.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=2240

On this front, the report reveals that the demand for histopathology testing equipment across emerging economies in Asia Pacific such as China and India is projected to expand at a higher rate. According to United Nations, the number of aging population in India is expected to rise by 64 percent doing the 2015-2030 timeline, whereas China is likely to reflect a 71 percent increase in same time frame. This aspect continues to influence the use of histopathology testing equipment in a bid to reduce mortalities and facilitate health to the aged.

The demand for histopathology testing equipment for disease diagnosis applications is projected to expand at a stellar pace in the future. 2017 witnessed a positive spike in sales of histopathology testing equipment for disease diagnosis and the status quo is likely to continue in 2018 and ahead. Use of histopathology testing equipment in drug discovery is another field triggering the sales of histopathology testing equipment, in turn supporting growth of the overall histopathology testing equipment market, according to the report.

Histopathology testing equipment sales are largely concentrated among diagnostic centers, followed by hospital based laboratories. Sales of histopathology testing equipment among diagnostic centers maintained a 1.4x lead over those in hospitals and the trend is expected to continue in the long run, according to Fact.MR.

Get More Insights- https://www.prnewswire.com/news-releases/consumables-spearhead-gains-in-histopathology-testing-equipment-market-as-sales-likely-to-reach-us-5-5-billion-in-2018-says-fact-mr-888579674.html

The outlook of the histopathology testing equipment market is likely to remain positive in the future, with the market proceeding at a value CAGR of 4.8% throughout the 2018-2028 timeline.

Explore Fact.MR’s Coverage on the Healthcare Domain

Radiation proctitis treatment market: A recent study by Fact.MR on the radiation proctitis treatment market offers a 10-year forecast analysis for the period 2018 to 2028. The study analyzes key trends that are currently determining the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Radiation Nephropathy Treatment and Management Market: Fact. MR’s extensive coverage on the radiation nephropathy treatment and management market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Cancer therapeutics market: The global cancer therapeutics market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/2240/histopathology-testing-equipment-market
Press Release: https://www.factmr.com/media-release/723/histopathology-testing-equipment-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Burgeoning Demand for Single-Lumen Microcatheters In Healthcare Facilities to Uphold Market Growth: Report Fact.MR

As per Fact.MR – a market research and competitive intelligence provider, the global sales of coronary microcatheters was valued at around US$ 179 Mn in 2020, and is predicted to expand at a CAGR of 6.7% over the forecast period (2021–2031).

Factors boosting demand for coronary microcatheters include rapid adoption of innovative technologies in the healthcare sector and increasing prevalence of cardiovascular diseases across the world. Moreover, increasing number of players in the market is going to make this space highly competitive and also opportunistic. Diseases such as myocardial infarction and number of patients undergoing cardiology procedures such as angioplasty are increasing demand for coronary microcatheters.

To remain ‘ahead’ of your competitors, request a sample
https://www.factmr.com/connectus/sample?flag=S&rep_id=3971

 “Increasing adoption of steerable microcatheters is expected to drive market growth over the coming years,” says an analyst of Fact.MR.

coronary microcatheters market product by FactMR

Coronary Microcatheters Categorization as Per Industry Research

  • By Product

    • Single-lumen Coronary Microcatheters
    • Dual-lumen Coronary Microcatheters
    • Guide Extension Coronary Microcatheters

  • By Tip Type

    • Steerable Coronary Microcatheters
    • Angled Tip Coronary Microcatheters
    • Straight Tip Coronary Microcatheters

  • By Material

    • Stainless Steel Coronary Microcatheters
    • Stainless Steel+ Polytetrafluoroethylene – PTFE Coronary Microcatheters
    • Tungsten-braided Shaft Coronary Microcatheters
    • Platinum/Tungsten Coil Coronary Microcatheters
    • Others

  • End User

    • Coronary Microcatheters for Hospitals
    • Coronary Microcatheters for Ambulatory Surgical Centers
    • Coronary Microcatheters for Cardiac Catheterization Laboratories
    • Coronary Microcatheters for Specialty Clinics

For Comprehensive Insights Ask An Analyst Here
https://www.factmr.com/connectus/sample?flag=AE&rep_id=3971

Key Takeaways from Market Study

  • Single-lumen coronary microcatheters expected to contribute more than 52% revenue share in the market by 2031.
  • Demand for angled tip coronary microcatheters expected to increase at a CAGR of 7.6% due to their mandatory use in angled lesions or vessels.
  • Hospitals to dominate the market among all end-user segments and expected to reach US$ 287.8 Mn by 2031.
  • The U.S. holds a prominent share in the global market due to increasing number of coronary microcatheter manufacturing companies in the country. This market is expected to rise at a CAGR of 7.2% through 2031.

Get Customization on this Research Report for specific research solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=3971

Market Driver

Obesity has become a major risk factor for a variety of cardiovascular disorders around the globe. Obesity creates an inappropriate or excessive accumulation of fats inside the artery lumen, which can lead to a variety of health issues, including coronary heart disease. Thus, increasing rate of obesity will drive demand for coronary microcatheters across the world over the coming years.

Who is Winning?

The global coronary microcatheters market is set to grow due to rise in demand for minimally invasive procedures. Leading industry players are set to focus on research & development as well as strategic & geographic expansions in order to strengthen their presence across regions.

  • Boston Scientific Corporation
  • Teleflex Corporation
  • ASAHI INTECC USA, INC.
  • Medtronic
  • Terumo Corporation
  • KANEKA CORPORATION
  • CookMerit Medical Systems
  • Merit Medical Systems
  • Nipro Corporation
  • OrbusNeich Medical Company Limited
  • Baylis Medical Company, Inc
  • Interventional Medical
  • Device Solutions (IMDS)

For More Insights https://www.biospace.com/article/cardiac-ablation-technologies-market-growth-will-be-driven-by-high-reliance-of-electro-physiologists-on-new-ablation-devices-fact-mr/

Want more insights?

Fact.MR brings a comprehensive research report on forecasted revenue growth at the global, regional, and country levels, and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031.

The coronary microcatheters market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the basis of product, tip type, material, and end user, and main regions.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Demand for ELISA Test for Poultry Diagnostics In Asia Pacific Is Anticipated to Surge at an Impressive CAGR of 11% : Fact.MR

The global sales of poultry diagnostics are projected to expand at a healthy CAGR of 9% till 2031, surpassing US$ 660 Mn in valuation, reports Fact.MR, a market research and competitive intelligence provider. Historical data suggests that the market expanded at a CAGR of 8.3% from 2016 to 2020.

The primary cause for significant growth in demand for poultry diagnostics is rising outbreaks of poultry diseases worldwide. These flock infections affect world trade in layers poultry, broilers, and turkeys. As a result, ongoing efforts are being made to increase awareness among farmers about these diseases. Different bacteria, fungi, viruses, protozoon pathogens, and environment and nutritional deficiencies are causing these diseases.

To remain ‘ahead’ of your competitors, request a sample
https://www.factmr.com/connectus/sample?flag=S&rep_id=6747

Rising prevalence of these infectious diseases and growing threat of antibiotic resistant microbes are key factors bolstering demand for poultry diagnostics across the world. Also, concerns of bacterial and viral transmission from birds to human consumers is supporting the use of diagnostics, as poultry consumption continues growing worldwide.

“Growing incidence of zoonotic diseases and rising awareness of consumers towards safety of poultry products to boost demand for poultry diagnostics over coming years,” says a Fact.MR analyst.

Key Segments Covered in Poultry Diagnostics Industry Research

  • By Test

    • ELISA Test (Enzyme-linked Immunoassays)
    • PCR Test (Polymerase Chain Reaction)

  • By Disease

    • Avian Salmonellosis
    • Avian Influenza
    • Newcastle Disease
    • Avian Mycoplasmosis
    • Avian Pasteurellosis
    • Infectious Bronchitis
    • Infectious Bursal Disease
    • Avian Encephalomyelitis
    • Avian Reovirus
    • Chicken Anaemia

  • By Service

    • Bacteriology
    • Virology
    • Parasitology

For Comprehensive Insights Ask An Analyst Here
https://www.factmr.com/connectus/sample?flag=AE&rep_id=6747

Key Takeaways from Market Study

  • By test, ELISA to generate 52% of total market revenue.
  • Market for poultry diagnostics to grow 1.8X in value by 2031.
  • U.S. to remain dominant in North American market expanding at 6% CAGR through 2031.
  • Market for poultry diagnostics in China to surge at CAGR of 12% over analysis period.
  • Within Europe, market in Germany to expand at a CAGR of 7% over next ten years.
  • Demand for PCR tests to rise at a CAGR of 8% over the decade.

Get Customization on this Research Report for specific research solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=6747

Key Players

  • IDEXX Laboratories
  • QIAGEN N.V.
  • Thermo Fisher Scientific
  • Zoetis
  • GD Animal Health
  • IDvet
  • AffiniTech LTD
  • AgroBioTek Internacional
  • BioNote
  • BioChek
  • Boehringer Ingelheim
  • MEGACOR Diagnostik GmbH
  • BioInGenTech Biotechnologies.

For More Insights 
https://www.biospace.com/article/increasing-application-in-oncology-and-cancer-treatment-propelling-human-umbilical-vein-endothelial-cells-huvec-market-growth-fact-mr/

More Valuable Insights

Fact.MR, in its new offering, presents an unbiased analysis of the poultry diagnostics market, presenting historical market data (2016-2020) and forecast statistics for the period of 2021-2031.

The study reveals essential insights on the basis of test (ELISA test and PCR test), disease (avian salmonellosis, avian influenza, Newcastle disease, avian mycoplasmosis, avian pasteurellosis, infectious bronchitis, infectious bursal disease, avian encephalomyelitis, avian reovirus, and chicken anaemia), and service (bacteriology, virology, and parasitology), across major regions of the world (North America, Europe, Asia Pacific, Central & South America, and the Middle East & Africa).

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Demand of Respiratory Syncytial Virus (RSV) Molecular Diagnostics Is Predicted to Grow at a Staggering CAGR of 9% By 2031

Fact.MR, a market research and competitive intelligence provider, projects the global demand for respiratory syncytial virus (RSV) diagnostics to progress positively, surging at a CAGR of above 9% across the 2021-2031 forecast period.

Growing demand for point of care testing of respiratory syncytial virus (RSV)-infected patients and developments in the field of specific markers such as proteomics and genomic are set to accelerate market growth over the coming years.

Increase in the number of patients suffering from RSV infections has raised the overall burden of the disease, and, as such, has fuelled demand for RSV diagnostics globally. Approval of respiratory syncytial virus diagnostic assays & kits is further opening up various opportunities for market players.

To remain ‘ahead’ of your competitors, request a sample
https://www.factmr.com/connectus/sample?flag=S&rep_id=6736

North America dominates the market for respiratory syncytial virus diagnostics due to advanced technologies and innovation across the region, while the market in Asia Pacific is expected to surge at a high growth rate over the forecast period due to increasing burden of RSV infections among the population.

“Growing incidence of respiratory syncytial virus infections globally to boost demand for RSV diagnostics over coming years,” says a Fact.MR analyst.

respiratory syncytial virusrsv diagnostics market by FactMR

Key Market Segments Covered in Respiratory Syncytial Virus Diagnostics Industry Research

  • By Technology

    • RSV Molecular Diagnostics
    • RSV Monoclonal Antibodies
    • Immunoassays
    • Differential Light Scattering
    • Artificial Intelligence
    • Liposomes
    • Flow Cytometry
    • Chromatography
    • Diagnostic Imaging
    • Gel Microdroplets

  • By End Users

    • Respiratory Syncytial Virus Diagnostics at Hospitals
    • Respiratory Syncytial Virus Diagnostics at Nursing Homes
    • Respiratory Syncytial Virus Diagnostics at Commercial Laboratories
    • Respiratory Syncytial Virus Diagnostics at Public Health Laboratories

For Comprehensive Insights Ask An Analyst Here
https://www.factmr.com/connectus/sample?flag=AE&rep_id=6736

Key Takeaways from Market Study

  • Market for respiratory syncytial virus diagnostics to grow 2.3X in value by 2031, and reach a valuation of US$ 1.3 Bn by 2031.
  • RSV diagnostic kits & assays account for more one-third of the global market share.
  • Market for RSV diagnostics in China to top US$ 253 Mn by 2031.
  • Demand for respiratory syncytial virus diagnostics in Canada to increase at CAGR of 7.4%.
  • Market in Japan anticipated to expand at CAGR of 6% from 2021 to 2031.
  • New technological advancements in the field of diagnostics to boost market growth over next 10 years.

Get Customization on this Research Report for specific research solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=6736

Winning Strategy of Key Market Players

Various companies are focusing on organic growth strategies such as product launches, product approvals, and patents. Inorganic growth activities witnessed in the market are acquisitions and partnership & collaborations.

  • Abbott Laboratories
  • Becton
  • Dickinson and Company
  • BioMérieux SA
  • Bio-Rad Laboratories
  • Coris BioConcept
  • DiaSorin Molecular LLC (DiaSorin Inc)
  • F. Hoffmann-La Roche AG
  • Merck KgaA
  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • Thermo Fisher Scientific

For More Insights https://www.biospace.com/article/rising-cases-of-microbial-diseases-add-to-already-high-demand-for-antimicrobial-susceptibility-tests-fact-mr-study/

More Valuable Insights

Fact.MR, in its new offering, presents an unbiased analysis of the respiratory syncytial virus diagnostics market, presenting historical market data (2016-2020) and forecast statistics for the period of 2021-2031.

The study reveals essential insights on the basis of technology (molecular diagnostics, monoclonal antibodies, immunoassay, differential light scattering, artificial intelligence, liposomes, flow cytometry, chromatography, diagnostic imaging, and gel microdroplets) and end user (hospitals, nursing homes, commercial laboratories, and public health laboratories), across major regions of the world (North America, Europe, Asia Pacific, Central & South America, and the Middle East & Africa).

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com